Key terms
About PRPO
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PRPO news
Mar 26
4:53pm ET
Precipio Inc Schedules Year-End Shareholder Update Call
Feb 06
10:05am ET
Precipio trading resumes
Feb 06
10:01am ET
Precipio, Cardinal Health enter distribution agreement for HemeScreen portfolio
Feb 06
10:00am ET
Precipio trading halted, volatility trading pause
Jan 23
10:04am ET
Precipio reports Q4 cash burn from operations below $100,000
Jan 17
10:40am ET
Precipio trading resumes
Jan 17
10:31am ET
Precipio enters distribution agreement for IV-Cell, HemeScreen in Japan
Jan 17
10:30am ET
Precipio trading halted, volatility trading pause
Jan 02
9:08am ET
Precipio appoints Christina Valauri to board of directors
No recent news articles are available for PRPO
No recent press releases are available for PRPO
PRPO Financials
Key terms
Ad Feedback
PRPO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PRPO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range